Skip to main navigation Skip to search Skip to main content

Utility of Endobronchial Valves in a Patient with Bronchopleural Fistula in the Setting of COVID-19 Infection: A Case Report and Brief Review

  • HCA Healthcare

Research output: Contribution to journalArticlepeer-review

Abstract

Patients with COVID-19 pneumonia frequently develop acute respiratory distress syndrome (ARDS), and in severe cases, require invasive mechanical ventilation. One complication that can develop in patients with ARDS who are mechanically ventilated is a bronchopleural fistula (BPF). Although rare, the frequency of BPF in patients with COVID-19 pneumonia is increasingly recognized. Here, we present a 48-year old man with BPF associated with COVID-19 pneumonia. Treatment with a commercial endobronchial valve (EBV) system resulted in reduced air leak allowing for tracheostomy placement. Our case adds to a growing body of evidence suggesting that the presence of COVID-19 pneumonia does not hinder the utility of EBV’s in the treatment of BPF’s.

Original languageAmerican English
JournalInternal Medicine
StatePublished - Oct 29 2021

Keywords

  • COVID-19
  • Novel Coronavirus 2019
  • SARS-CoV-2
  • pneumonia
  • bronchopleural fistula

Disciplines

  • Internal Medicine
  • Respiratory Tract Diseases
  • Virus Diseases

Cite this